QHSLab, Inc. splits its revenue into 5 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Integrated Service Program at $1.1 million, 42% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3
|
3
|
2
|
1
|
1
|
1
|
0
|
—
|
—
|
—
|
—
|
| Integrated Service Program |
2
+99.6%
share 51.7%
|
1
+74.3%
share 41.7%
|
1
+138.2%
share 30.2%
|
0
share 19.2%
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
| Allergy Diagnostic Kit Sales |
1
-9.5%
share 26.0%
|
1
share 30.6%
|
—
|
1
share 47.3%
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
| Immunotherapy Treatment Sales |
0
+1.8%
share 15.1%
|
0
+19.2%
share 18.1%
|
0
+12.7%
share 19.2%
|
0
share 25.8%
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
| Clinical Study Revenue |
0
share 2.5%
|
0
+0.0%
share 5.0%
|
0
share 6.3%
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
| Subscription Revenue |
0
+8.6%
share 1.5%
|
0
-19.8%
share 1.6%
|
0
-24.5%
share 2.6%
|
0
share 5.1%
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- USAQ (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- West Palm Beach, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 856984
- Former names
- USA EQUITIES CORP. (until Apr 19, 2022); AMERICAN BIOGENETIC SCIENCES INC (until Nov 16, 2015)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.